Key statistics
On Tuesday, Arrowhead Pharmaceuticals Inc (HDP1:STU) closed at 13.30, 54.63% above the 52 week low of 8.60 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.30 |
---|---|
High | 13.30 |
Low | 13.30 |
Bid | 13.58 |
Offer | 13.72 |
Previous close | 13.59 |
Average volume | 0.00 |
---|---|
Shares outstanding | 138.10m |
Free float | 118.88m |
P/E (TTM) | -- |
Market cap | 2.18bn USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of Jul 01 2025.
More ▼
Press releases
- Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
- Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
- Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results
- Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
- Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Second Quarter Results
- Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
- Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
More ▼